Abstract
Introduction
Recent studies have suggested a rise in the incidence of testicular germ-cell tumors (TGTs) in the last years, mainly due to an increase of early stage cases. We analysed the time trends in biological features of these patients in order to confirm this tendency in our environment.
Materials and methods
The clinical records of 136 consecutive patients with TGTs treated at a single institutions over a 20-year period (1984–2003) were retrospectively reviewed. Pathological, clinical, therapeutic and outcome data were collected. Patients were allocated into four consecutive 5-year intervals and their characteristics were compared by means of the chi-squared test. The survival analysis was performed with the method of Kaplan and Meier.
Results
A progressive increase in the incidence of new cases, and a more frequent diagnosis of stage I versus stage II–IV disease was confirmed within this time period. It was also observed a greater use of postorchiectomy chemotherapy, mainly due to an increase in the adjuvant indications. A significant decrease in the recurrence rate was noted. Ten-year overall survival was 86.5%. There was a trend for improved outcome, but the differences among the two decades were not statistically significant.
Conclusions
A real increase in the incidence of TGTs and in the proportion of early stages was confirmed. This may be due to an epidemiological change or to an earlier diagnosis. This new pattern is associated with a more frequent use of adjuvant chemotherapy and with a reduction in the relapse rate.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Garner MJ, Turner MC, Ghadirian P, Krewski D. Epidemiology of testicular cancer: An overview. Int J Cancer. 2005; 116:331–9.
Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer wordwide: a review. J Urol. 2003;170:5–11.
Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA. International patterns and trends in testis cancer incidence. Int J Cancer. 2005;115:822–7.
Bosl GJ, Motzer RJ. Testicular germ-cell cancer. New Engl J Med. 1997;337:242–55.
Jones RH, Vasey PA. Part I: testicular cancer-management of early disease. Lancet Oncol. 2003;4:730–7.
Scholz M, Holtl W. Stage I testicular cancer. Curr Opin Urol. 2003;13:473–6.
Jones RH, Vasey PA. Part II: testicular cancer-management of advanced disease. Lancet Oncol. 2003;4:758–47.
Sonneveld DJ, Hoekstra HJ, Van Der Graaf WT, et al. The changing distribution of stage in nonseminomatous testicular germs cell tumours, from 1977 to 1996. BJU Int. 1999;84:68–74.
Hermanek P, Sobin LH: UICC: TNM Classification of Malignant Tumours, 5th edition. Berlin: Springer; 1997.
International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ-cell cancers. J Clin Oncol. 1997;15: 594–605.
Huddard RA, Birtle AJ. Recent advances in the treatment of testicular cancer. Expert Rev Anticancer Ther. 2005;5:123–38.
Boyle P. Testicular cancer: the challenge for cancer control. Lancet Oncol. 2004;5: 56–61.
Germá-Lluch JR, García del Muro X, Maroto P, et al. Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumors of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG). Eur Urol. 2002;42:553–62.
Mostofi FK, Sesterhenn IA, Davis CJ Jr. Developments in histopathology of testicular germ cell tumors. Semin Urol. 1988; 6:171–88.
Pearce N, Sheppard RA, Howard JK, et al. Time trends and occupational differences in cancer of the testis in New Zealand. Cancer. 1987;59:1677–82.
Moller H, Skakkebaek NE. Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark. Cancer Causes Control. 1997;8: 904–12.
Weir HK, Marrett LD, Kreiger N, et al. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer. 2000;87:438–43.
Pettersson A, Kaijser M, Richiardi L, et al. Women smoking and testicular cancer: one epidemic causing another? Int J Cancer. 2004;109:941–4.
Heimdal K, Fossa SD, Johansen A. Increasing incidence and changing stage distribution of testicular carcinoma in Norway 1970–87. Br J Cancer. 1990;62:277–8.
Krag Jacobsen G, Barlebo H, Olsen J, et al. Testicular germ cell tumours in Denmark 1976–80. Pathology of 1058 consecutive cases. Acta Radiol Oncol. 1984;23:239–47.
Mead GM, Stenning SP, Parkinson MC, et al. The second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumours. J Clin Oncol. 1992;10:85–94.
Moul JW, Paulson DF, Dodge RK, Walther PJ. Delay in diagnosis and survival in testicular cancer: impact of effective therapy and changes during 18 years. J Urol. 1990;143:520–3.
Thornhill JA, Fennelly JJ, Kelly DG, et al. Patients' delay in the presentation of testis cancer in Ireland. Br J Urol. 1987;59:447–51.
Chilvers CED, Saunders M, Bliss JM, et al. Influence of delay in diagnosis on prognosis in testicular teratoma. Br J Cancer. 1989;59:126–8.
Kuczyc M, Bokemeyer C, Hartmann JT. Advances in our understanding of the biology, new diagnostic approaches and recent treatment strategies for testicular germ cell cancer. World J Urol. 2004;22:1.
Balk C, Witjes JA. Advances in the management of testicular cancer. Expert Rev Anticancer Ther. 2004;4:669–77.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saera, J.M., Urtasun, J.A., Beveridge, R.D. et al. Epidemiological pattern and time trends in testicular germ-cell tumors: a single institution 20-year experience. Clin Transl Oncol 8, 588–593 (2006). https://doi.org/10.1007/s12094-006-0064-2
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s12094-006-0064-2